Kaslow David C Md - Net Worth and Insider Trading
Kaslow David C Md Net Worth
The estimated net worth of Kaslow David C Md is at least $0 dollars as of 2024-12-15. Kaslow David C Md is the Chief Scientific Officer of Fresh Tracks Therapeutics Inc and owns about 0 shares of Fresh Tracks Therapeutics Inc (FRTX) stock worth over $0. Details can be seen in Kaslow David C Md's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kaslow David C Md has not made any transactions after 2003-08-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kaslow David C Md
Kaslow David C Md Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kaslow David C Md owns 1 companies in total, including Fresh Tracks Therapeutics Inc (FRTX) .
Click here to see the complete history of Kaslow David C Md’s form 4 insider trades.
Insider Ownership Summary of Kaslow David C Md
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2003-08-07 | Chief Scientific Officer |
Kaslow David C Md Latest Holdings Summary
Kaslow David C Md currently owns a total of 1 stock. Kaslow David C Md owns 0 shares of Fresh Tracks Therapeutics Inc (FRTX) as of August 7, 2003, with a value of $0.
Latest Holdings of Kaslow David C Md
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2003-08-07 | 0 | 0.75 | 0 |
Holding Weightings of Kaslow David C Md
Kaslow David C Md Form 4 Trading Tracker
According to the SEC Form 4 filings, Kaslow David C Md has made a total of 0 transactions in Fresh Tracks Therapeutics Inc (FRTX) over the past 5 years. The most-recent trade in Fresh Tracks Therapeutics Inc is the acquisition of 0 shares on August 7, 2003, which cost Kaslow David C Md around $1,643.
Insider Trading History of Kaslow David C Md
- 1
Kaslow David C Md Trading Performance
GuruFocus tracks the stock performance after each of Kaslow David C Md's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kaslow David C Md is 25.24%. GuruFocus also compares Kaslow David C Md's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kaslow David C Md within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kaslow David C Md's insider trading performs compared to the benchmark.
Performance of Kaslow David C Md
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 25.44 | | | | | |
| Relative Return to S&P 500(%) | 20.59 | | | | | |
Kaslow David C Md Ownership Network
Ownership Network List of Kaslow David C Md
Ownership Network Relation of Kaslow David C Md
Kaslow David C Md Owned Company Details
What does Fresh Tracks Therapeutics Inc do?
Who are the key executives at Fresh Tracks Therapeutics Inc?
Kaslow David C Md is the Chief Scientific Officer of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .
Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary
Over the past 18 months, Kaslow David C Md made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 1,086,412 shares were bought by its insiders, resulting in a net purchase of 1,086,302 shares.
Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fresh Tracks Therapeutics Inc Insider Transactions
Kaslow David C Md Mailing Address
Above is the net worth, insider trading, and ownership report for Kaslow David C Md. You might contact Kaslow David C Md via mailing address: 9373 Towne Centre Drive Suite 100, San Diego Ca 92121-3088.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
